Open AccessGoal of a “Good Death” in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close?
Author(s) -
Thomas M. Kuczmarski,
Oreofe O. Odejide
Publication year - 2021
Publication title -
current hematologic malignancy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.299
H-Index - 35
eISSN - 1558-822X
pISSN - 1558-8211
DOI - 10.1007/s11899-021-00629-1
Subject(s) - medicine , palliative care , intensive care medicine , end of life care , psychological intervention , quality of life (healthcare) , health care , hematology , population , cause of death , hospice care , hematologic neoplasms , emergency medicine , family medicine , cancer , nursing , disease , environmental health , economics , economic growth
The medical field has a critical role not only in prolonging life but also in helping patients achieve a good death. Early studies assessing end-of-life quality indicators to capture if a good death occurred demonstrated low rates of hospice use and high rates of intensive healthcare utilization near death among patients with hematologic malignancies, raising concerns about the quality of death. In this review, we examine trends in end-of-life care for patients with hematologic malignancies to determine if we are close to the goal of a good death.